Topical insulin for refractory persistent corneal epithelial defects
David Díaz‐Valle(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), J.M. Benítez-del-Castillo(Universidad Complutense de Madrid), Pilar Peña-Urbina(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Virginia Puebla-García(Hospital Clínico San Carlos), Sara García-Caride(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), J.A. Gegúndez-Fernández(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Barbara Burgos‐Blasco(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos)
Cited by 59
Related Papers
Conjunctivitis in COVID-19 patients: frequency and clinical presentation
|Graefe s Archive for Clinical and Experimental Ophthalmology|2020|86
Detecting SARS‐CoV‐2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID‐19?
|Journal of Medical Virology|2020|81
Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea
|Acta Ophthalmologica|2021|68
Tear and aqueous humour cytokine profile in primary open‐angle glaucoma
|Acta Ophthalmologica|2020|62
Optic nerve and macular optical coherence tomography in recovered COVID-19 patients
|European Journal of Ophthalmology|2021|51